Calecim, read like a paper

In one breath. Calecim sells a "stem cell" skincare line built on PTT-6, the conditioned medium of red deer umbilical cord lining cells. The website talks in 500 to 700 percent thickness gains, 24 percent hair follicle growth and "3,000 messaging signals". The one randomized, double-blind, vehicle-controlled trial on the face, 40 people, three months, run at a serious San Diego clinic, found that blinded investigators could not tell the treated side from the vehicle side. Only the participants could. That is the whole story, and it is a story about how a real journal paper turns into a marketing page.

What it is, in their words and in plain ones

Their words (calecimpro.com, "Our science" and "Technology" pages, read Sep 26, 2026): PTT-6 is "the secretion of these stem cells that contains all the powerful actives", "over 3,000 messaging signals such as Growth Factors, Cytokines, Peptides & Exosomes", made "from the umbilical cord lining membrane of red deer", and the cells "direct skin cells to behave in a youthful manner by sending 'Youth Messages'".

Plain ones: there are no stem cells in the jar. Cord lining cells from deer are grown in a dish, the liquid they were sitting in is collected, and that liquid (conditioned medium) goes into the cream. Conditioned medium is a real thing; every cell biologist has made it. It is also, by definition, a soup of whatever the cells secreted plus whatever was in the growth medium. "3,000 signals" is a count of proteins in a soup, not evidence that any of them cross the stratum corneum (most growth factors are 5,000 to 70,000 daltons; the door is about 500).

The parent company, CellResearch Corp (Singapore), does have serious work: cord lining stem cells were characterised there in 2004 and the company has an FDA Phase 1 for diabetic wounds. That is a human cell therapy applied to an open wound. It is not a deer-cell soup applied to intact facial skin, and the website leans on the first to sell the second.

The numbers on the website, and where each one comes from

• "increased epidermal and dermal thickness of between 500% to 700%": no study cited on the page. Language of this kind usually comes from skin explants or cell cultures, not people. Ask them for the paper.
• "proliferate and migrate to close scrape wound in only 40 hours": a scratch assay. Cells in a dish, a scratch with a pipette tip, a timer. Standard lab exercise, no skin involved.
• "83% increase in Hyaluronic Acid expression", "56% increase in Elastin expression", "600% increase in Dermal and Epidermal Fullness": no design, no n, no duration on the page.
• "24% increase in the growth of hair follicle cells", "reduce inflammation by 30 times", "100% felt hair softer", "97% felt hair thicker": the first two are unreferenced, the rest are a questionnaire.

What the published papers actually show

1. Alhaddad, Boen, Wu and Goldman, Journal of Drugs in Dermatology, 2019. "Prospective, randomized, double-blind, split-face, placebo-controlled clinical trial." Forty healthy subjects with moderate to severe facial wrinkling, three months, the cream on one side, vehicle on the other. Result, quoted: "Both sides of the face achieved significant improvement. Blinded investigator assessments did not detect any statistically significant differences between the two halves of the face in terms of efficacy, safety, or tolerability. Subject evaluations demonstrated superiority of the active treatment side." This is the best trial on the product. Both sides improved (a moisturiser does that), the blinded doctors saw no difference, and the people using it preferred the side they were told nothing about. That last line is the one the marketing keeps.
2. Hoss, Kollipara, Alhaddad, Boen and Goldman, JDD, 2020. Twenty patients after ablative resurfacing, randomized, double-blind, vehicle control. Abstract reports "a trend towards decreased facial erythema and crusting" and greater wrinkle improvement with the active product; no p values in the abstract. A trend in twenty people after a laser is a reason to run a bigger study, not a claim.
3. Dermatologic Surgery, 2025 (the eyelid paper the brand quotes). Two parts. In a dish: fibroblasts from nine donors, 48 hours, the conditioned medium raised hyaluronic acid and elastin staining by 113 and 68 percent against plain culture medium. In people: four volunteers, all already Calecim users, 35 days, no control, photographs scored by the investigator. The cell work was done by CellResearch Corporation, the parent company. Four existing customers with no control arm is a case series, and the brand's blog headline turns it into "PTT-6 stimulates elastin and hyaluronic acid production in eyelid skin".

Both sides improved, the blinded doctors saw no difference, and the people using it preferred the side they were told nothing about. That last line is the one the marketing keeps.

Where the claim slips

The chain runs: real cell biology (2004, cord lining stem cells) to a human wound-healing programme (FDA Phase 1) to deer-cell conditioned medium in a cream to dish numbers presented as skin numbers to one proper trial that came out flat for the blinded readers to a website that quotes the dish and the questionnaires and not the trial's investigator line.

Nothing here is illegal on its face; the US footer says cosmetic, not drug, not FDA approved. It is the ordinary gap between what the evidence shows and what the page implies, and it is a wide one.

What a careful reader asks

• Which of these percentages was measured on a person, and in how many people?
• Is there a vehicle-controlled trial, and what did the blinded assessors find?
• How big are the actives, and how do they cross intact skin?
• Is the wound-healing work the same product, the same species, the same route?

Keep reading

If you own a stem cell cream and want to know what it is doing for your skin, that is what a consultation is for: your routine, your history, and the honest read on each product, with no upsell.

Two more from the Journal: Salmon DNA, and the 500 dalton problem, on why molecular size decides what a serum can reach, and Peptides, ranked by evidence, for the signal molecules that do have human trials behind them. Brands: this is the kind of read a product page gets on What I check.

Sources

Every line above maps to a page or a paper. This is education, not medical advice.

• calecimpro.com/pages/our-science and /pages/technology; calecimprofessional.com blog "most ethical source of stem cells" (red deer statement) and "PTT-6 stimulates elastin and hyaluronic acid production in eyelid skin" (read Sep 26, 2026).
• Alhaddad M, Boen M, Wu DC, Goldman MP. Red Deer Umbilical Cord Lining Mesenchymal Stem Cell Extract Cream for Rejuvenation of the Face. J Drugs Dermatol 2019 (PubMed 31012565). Abstract read on jddonline.com.
• Hoss E, Kollipara R, Alhaddad M, Boen M, Goldman MP. Red Deer Umbilical Cord-Derived Stem Cell Conditioned Media Combined With Ablative Resurfacing of the Face. J Drugs Dermatol 2020. Abstract read on jddonline.com.
• Red Deer Umbilical Cord Lining Mesenchymal Stem Cell-Conditioned Media Stimulates Fibroblast Elastin and Hyaluronic Acid Production to Improve Eyelid Aesthetics. Dermatol Surg, doi 10.1097/DSS.0000000000004810 (paywalled; the details above are from the brand's own summary of the paper).